Mutual of America Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,878
Closed -$5.31M 1677
2021
Q2
$5.31M Buy
28,878
+394
+1% +$72.4K 0.05% 497
2021
Q1
$4.36M Buy
28,484
+916
+3% +$140K 0.05% 595
2020
Q4
$4.31M Sell
27,568
-874
-3% -$137K 0.05% 536
2020
Q3
$3.26M Sell
28,442
-1,363
-5% -$156K 0.04% 582
2020
Q2
$3.35M Sell
29,805
-355
-1% -$39.8K 0.05% 555
2020
Q1
$2.71M Buy
30,160
+107
+0.4% +$9.61K 0.05% 555
2019
Q4
$3.25M Sell
30,053
-6
-0% -$649 0.04% 678
2019
Q3
$2.94M Buy
30,059
+118
+0.4% +$11.6K 0.04% 691
2019
Q2
$3.92M Buy
29,941
+369
+1% +$48.3K 0.06% 522
2019
Q1
$4M Sell
29,572
-176
-0.6% -$23.8K 0.06% 517
2018
Q4
$2.9M Buy
29,748
+945
+3% +$92K 0.05% 613
2018
Q3
$4M Buy
28,803
+92
+0.3% +$12.8K 0.06% 524
2018
Q2
$3.56M Buy
28,711
+299
+1% +$37.1K 0.05% 588
2018
Q1
$3.17M Buy
28,412
+915
+3% +$102K 0.05% 628
2017
Q4
$3.29M Buy
27,497
+715
+3% +$85.5K 0.05% 614
2017
Q3
$3.76M Sell
26,782
-656
-2% -$92K 0.06% 517
2017
Q2
$3.34M Sell
27,438
-557
-2% -$67.8K 0.06% 564
2017
Q1
$3.39M Buy
27,995
+1,049
+4% +$127K 0.06% 540
2016
Q4
$3.3M Buy
26,946
+518
+2% +$63.4K 0.06% 526
2016
Q3
$3.24M Buy
26,428
+248
+0.9% +$30.4K 0.07% 495
2016
Q2
$3.06M Buy
26,180
+805
+3% +$94K 0.07% 485
2016
Q1
$3.53M Buy
25,375
+228
+0.9% +$31.7K 0.08% 367
2015
Q4
$4.8M Buy
25,147
+118
+0.5% +$22.5K 0.11% 225
2015
Q3
$3.91M Sell
25,029
-8,626
-26% -$1.35M 0.09% 289
2015
Q2
$6.08M Buy
33,655
+11,283
+50% +$2.04M 0.13% 151
2015
Q1
$3.88M Buy
22,372
+964
+5% +$167K 0.08% 337
2014
Q4
$3.96M Buy
21,408
+316
+1% +$58.5K 0.09% 319
2014
Q3
$3.5M Buy
21,092
+50
+0.2% +$8.29K 0.08% 341
2014
Q2
$3.29M Sell
21,042
-554
-3% -$86.6K 0.08% 398
2014
Q1
$3.29M Buy
21,596
+931
+5% +$142K 0.08% 389
2013
Q4
$2.75M Sell
20,665
-233
-1% -$31K 0.07% 488
2013
Q3
$2.43M Buy
20,898
+475
+2% +$55.2K 0.07% 487
2013
Q2
$1.88M Buy
+20,423
New +$1.88M 0.06% 596